Wnt signaling and colon carcinogenesis: beyond APC.

The many faces and functions of β-catenin. EMBO J (2012) 3.85

A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation (2012) 1.31

Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH. Sci Rep (2012) 1.26

Probing transcription-specific outputs of β-catenin in vivo. Genes Dev (2011) 1.18

Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep (2015) 1.02

Multispecies model of cell lineages and feedback control in solid tumors. J Theor Biol (2012) 0.95

Important molecular genetic markers of colorectal cancer. Oncotarget (2016) 0.94

The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. Mol Cell Ther (2015) 0.94

Retracted Specific armadillo repeat sequences facilitate β-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem (2011) 0.94

Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr (2011) 0.89

A novel signaling pathway regulates colon cancer angiogenesis through Norrin. Sci Rep (2014) 0.85

New insights into the regulation of Axin function in canonical Wnt signaling pathway. Protein Cell (2014) 0.85

Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol (2014) 0.85

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells. Br J Cancer (2012) 0.84

Wnt modulating agents inhibit human cytomegalovirus replication. Antimicrob Agents Chemother (2013) 0.84

Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival. Oncotarget (2015) 0.83

Intersection of AHR and Wnt signaling in development, health, and disease. Int J Mol Sci (2014) 0.82

Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene (2015) 0.82

Development of cancer-initiating cells and immortalized cells with genomic instability. World J Stem Cells (2015) 0.82

Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers. PLoS One (2013) 0.81

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med (2013) 0.81

I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs. Nat Prod Rep (2016) 0.80

Nutrient-induced intestinal adaption and its effect in obesity. Physiol Behav (2014) 0.79

Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics (2016) 0.79

Nucleoporin 62-like protein activates canonical Wnt signaling through facilitating the nuclear import of β-catenin in zebrafish. Mol Cell Biol (2015) 0.79

Targeting cancer stem cells by using the nanoparticles. Int J Nanomedicine (2015) 0.79

The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor. Oncotarget (2015) 0.79

Functional and genetic analysis of the colon cancer network. BMC Bioinformatics (2014) 0.78

The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Oncotarget (2017) 0.77

The Role of the C-Clamp in Wnt-Related Colorectal Cancers. Cancers (Basel) (2016) 0.77

Wnt signaling inhibits CTL memory programming. Mol Immunol (2013) 0.77

Intestinal stem cells and stem cell-based therapy for intestinal diseases. Cytotechnology (2014) 0.77

Predicting mechanism of biphasic growth factor action on tumor growth using a multi-species model with feedback control. J Coupled Syst Multiscale Dyn (2013) 0.76

Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin. PLoS One (2013) 0.76

Our evolving view of Wnt signaling in C. elegans: If two's company and three's a crowd, is four really necessary? Worm (2012) 0.76

MicroRNA Signatures of Colonic Polyps on Screening and Histology. Cancer Prev Res (Phila) (2016) 0.76

MYC Deregulation in Primary Human Cancers. Genes (Basel) (2017) 0.75

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. Oncotarget (2016) 0.75

The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Therap Adv Gastroenterol (2016) 0.75

Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling. Oncotarget (2017) 0.75

Colorectal cancer risk genes are functionally enriched in regulatory pathways. Sci Rep (2016) 0.75

Feedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect. Bull Math Biol (2016) 0.75

Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer. PPAR Res (2017) 0.75

Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin. Sci Rep (2016) 0.75

Tumor suppressor genes in familial adenomatous polyposis. Gastroenterol Hepatol Bed Bench (2017) 0.75

Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway. Clin Transl Med (2017) 0.75

Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma. Cancer Sci (2016) 0.75

A multiobjective approach for identifying protein complexes and studying their association in multiple disorders. Algorithms Mol Biol (2015) 0.75

Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers. Oncotarget (2016) 0.75

Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation. Int J Mol Sci (2016) 0.75

Intestinal knockout of Nedd4 enhances growth of Apc(min) tumors. Oncogene (2016) 0.75

Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology. Funct Integr Genomics (2016) 0.75

Inhibitory Effect of 1,8-Cineol on β-Catenin Regulation, WNT11 Expression, and Cellular Progression in HNSCC. Front Oncol (2017) 0.75

A genetic model for colorectal tumorigenesis. Cell (1990) 44.37

Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80

Wnt signalling in stem cells and cancer. Nature (2005) 19.26

Wnt signaling and cancer. Genes Dev (2000) 18.53

Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31

Identification and characterization of the familial adenomatous polyposis coli gene. Cell (1991) 14.46

Identification of FAP locus genes from chromosome 5q21. Science (1991) 11.41

Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet (1998) 10.51

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol (2009) 9.43

Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature (2009) 9.15

Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99

Wnt signalling and its impact on development and cancer. Nat Rev Cancer (2008) 8.37

Association of the APC gene product with beta-catenin. Science (1993) 8.20

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol (2010) 7.73

Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol (2009) 7.29

Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell (2009) 7.08

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24

Towards an integrated view of Wnt signaling in development. Development (2009) 6.07

Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (1987) 5.46

Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov (2006) 5.29

Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet (2001) 5.09

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell (2004) 4.98

Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J (1991) 4.90

Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol (2005) 4.34

Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science (1999) 4.08

The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature (1999) 4.01

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A (2004) 3.95

The oncogenic activation of beta-catenin. Curr Opin Genet Dev (1999) 3.87

The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev (2006) 3.85

The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol (2003) 3.53

Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium (2005) 3.46

Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell (2002) 3.42

Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A (1998) 3.35

Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33

An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell (2004) 3.30

SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol (2004) 3.24

Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol (1998) 3.09

Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature (2005) 3.05

Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol (2008) 3.02

Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell (2008) 3.02

The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene (2005) 3.01

Diversity of LEF/TCF action in development and disease. Oncogene (2006) 2.84

A two-step model for colon adenoma initiation and progression caused by APC loss. Cell (2009) 2.80

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. Nat Chem Biol (2010) 2.71

Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol (2007) 2.70

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 2.69

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma. Blood (2009) 2.61

Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res (1994) 2.61

Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells. Nature (2008) 2.47

Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res (2009) 2.37

The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res (2004) 2.16

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer (2008) 2.13

Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development (2002) 2.11

The opposing roles of Wnt-5a in cancer. Br J Cancer (2009) 2.07

Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene (2005) 2.06

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene (2006) 2.05

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res (2007) 1.93

Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry (2005) 1.92

The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res (2007) 1.90

Wnts as ligands: processing, secretion and reception. Oncogene (2006) 1.90

pygopus Encodes a nuclear protein essential for wingless/Wnt signaling. Development (2002) 1.82

Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene (2007) 1.81

Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res (2010) 1.81

Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res (2001) 1.80

RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol Cell (2010) 1.78

Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res (2005) 1.77

Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer (2010) 1.74

Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget (2010) 1.71

A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol Cell Biol (2007) 1.70

WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res (2008) 1.67

Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat Chem Biol (2009) 1.65

Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol (2000) 1.56

Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev (2004) 1.53

Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors (2005) 1.50

Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Biol (2006) 1.48

Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci U S A (1997) 1.45

Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42

Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol (2007) 1.36

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer. J Thorac Oncol (2010) 1.31

Shutting down Wnt signal-activated cancer. Nat Genet (2004) 1.26

Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol (2008) 1.25

Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol (2002) 1.25

Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res (2008) 1.24

Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes. Oncogene (2006) 1.23

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. Br J Cancer (2009) 1.21

Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer (1999) 1.19

Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch (2002) 1.15

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer (2008) 1.12

A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene (2009) 1.07

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res (2009) 1.05

Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. Oncogene (2010) 1.04

Overexpression of Wnt-2 in colorectal cancers. Neoplasma (2009) 1.03

Hedgehog drugs begin to show results. J Natl Cancer Inst (2008) 0.99

Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2. PLoS One (2009) 0.95

T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat Immunol (2009) 1.99

NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res (2010) 1.85

TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol (2012) 1.78

A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol Cell Biol (2007) 1.70

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res (2005) 1.55

hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin. Cancer Biol Ther (2007) 1.53

Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Biol (2006) 1.48

Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int (2012) 1.44

Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol (2004) 1.35

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther (2009) 1.34

A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation (2012) 1.31

A new beta-catenin-dependent activation domain in T cell factor. J Biol Chem (2003) 1.29

The LEF1/beta -catenin complex activates movo1, a mouse homolog of Drosophila ovo required for epidermal appendage differentiation. Proc Natl Acad Sci U S A (2002) 1.27

Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer (2009) 1.26

Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH. Sci Rep (2012) 1.26

Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res (2008) 1.24

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res (2007) 1.20

Developmental phenotypes and reduced Wnt signaling in mice deficient for pygopus 2. Genesis (2007) 1.15

Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci (2007) 1.15

A Wnt-fall for gene regulation: repression. Sci Signal (2008) 1.15

IRES-mediated pathways to polysomes: nuclear versus cytoplasmic routes. Trends Microbiol (2008) 1.07

An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA (2005) 1.07

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res (2009) 1.05

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int J Oncol (2005) 1.04

Molecular functions of the TLE tetramerization domain in Wnt target gene repression. EMBO J (2014) 1.02

Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach. Mol Cell Proteomics (2011) 1.02

A three-dimensional in vitro model of tumor cell intravasation. Integr Biol (Camb) (2014) 1.01

A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol Cell Biol (2012) 1.00

Wingless directly represses DPP morphogen expression via an armadillo/TCF/Brinker complex. PLoS One (2007) 0.99

Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2. PLoS One (2009) 0.95

Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol (2008) 0.94

A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res (2010) 0.93

Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol (2013) 0.92

Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol (2007) 0.92

Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther (2012) 0.89

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer Chemother Pharmacol (2011) 0.88

Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease. Oncol Rep (2007) 0.88

Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles. Int J Mol Med (2010) 0.87

Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anticancer Drugs (2003) 0.86

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecol Oncol (2012) 0.86

Ring Finger Protein 14 is a new regulator of TCF/β-catenin-mediated transcription and colon cancer cell survival. EMBO Rep (2013) 0.85

Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer. Anticancer Drugs (2006) 0.85

Blending hippo and WNT: sharing messengers and regulation. Cell (2012) 0.84

Microdevice to capture colon crypts for in vitro studies. Lab Chip (2010) 0.84

Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer (2007) 0.84

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (2011) 0.81

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. J Transl Med (2013) 0.81

Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer Chemother Pharmacol (2014) 0.79

Past visits present: TCF/LEFs partner with ATFs for β-catenin-independent activity. PLoS Genet (2013) 0.77

Coculture methodologies for the study of Wnt signals. Methods Mol Biol (2008) 0.77

Clinical pathways for pancreatic neuroendocrine tumors. J Gastrointest Cancer (2012) 0.76

Implementation of electronic chemotherapy ordering: an opportunity to improve evidence-based oncology care. J Oncol Pract (2013) 0.76

Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res (2013) 0.76

Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int (2013) 0.75

Standardized cancer incidence disparities in Upper Manhattan New York City neighborhoods: the role of race/ethnicity, socioeconomic status, and known risk factors. Eur J Cancer Prev (2016) 0.75

In situ hybridization to evaluate the expression of Wnt and frizzled genes in mammalian tissues. Methods Mol Biol (2008) 0.75

Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe. Drugs (2007) 0.75

Limitations of ADAMTS-13 activity level in diagnosing thrombotic thrombocytopenic purpura in pregnancy. Clin Appl Thromb Hemost (2008) 0.75

Developing clinical research incentives for academic oncologists. J Med Pract Manage (2015) 0.75

SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells. Anticancer Drugs (2015) 0.75

Does Hospital Size Affect Patient Satisfaction? Qual Manag Health Care (2017) 0.75